UBS Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $177M | Buy |
543,486
+264,848
| +95% | +$86.4M | 0.03% | 490 |
|
|
2025
Q1 | $75.2M | Sell |
278,638
-11,328
| -4% | -$3.06M | 0.01% | 896 |
|
|
2024
Q4 | $68.2M | Buy |
289,966
+134,295
| +86% | +$31.6M | 0.01% | 925 |
|
|
2024
Q3 | $42.8M | Sell |
155,671
-912
| -0.6% | -$251K | 0.01% | 898 |
|
|
2024
Q2 | $38M | Buy |
156,583
+32,120
| +26% | +$7.81M | 0.01% | 895 |
|
|
2024
Q1 | $18.6M | Buy |
124,463
+33,990
| +38% | +$5.08M | ﹤0.01% | 1238 |
|
|
2023
Q4 | $17.3M | Buy |
90,473
+20,571
| +29% | +$3.94M | 0.01% | 1160 |
|
|
2023
Q3 | $12.4M | Sell |
69,902
-3,641
| -5% | -$645K | ﹤0.01% | 1288 |
|
|
2023
Q2 | $14M | Buy |
73,543
+33,439
| +83% | +$6.35M | ﹤0.01% | 1250 |
|
|
2023
Q1 | $8.03M | Sell |
40,104
-7,247
| -15% | -$1.45M | ﹤0.01% | 1497 |
|
|
2022
Q4 | $11.3M | Buy |
47,351
+1,655
| +4% | +$393K | ﹤0.01% | 1313 |
|
|
2022
Q3 | $9.15M | Buy |
45,696
+20,629
| +82% | +$4.13M | ﹤0.01% | 1341 |
|
|
2022
Q2 | $3.66M | Sell |
25,067
-2,909
| -10% | -$424K | ﹤0.01% | 1979 |
|
|
2022
Q1 | $4.57M | Sell |
27,976
-61,497
| -69% | -$10M | ﹤0.01% | 1994 |
|
|
2021
Q4 | $15.2M | Buy |
89,473
+67,281
| +303% | +$11.4M | ﹤0.01% | 1271 |
|
|
2021
Q3 | $4.19M | Buy |
22,192
+3,543
| +19% | +$669K | ﹤0.01% | 2167 |
|
|
2021
Q2 | $3.16M | Sell |
18,649
-2,573
| -12% | -$436K | ﹤0.01% | 2367 |
|
|
2021
Q1 | $3M | Buy |
21,222
+82
| +0.4% | +$11.6K | ﹤0.01% | 2409 |
|
|
2020
Q4 | $2.75M | Sell |
21,140
-756
| -3% | -$98.2K | ﹤0.01% | 2359 |
|
|
2020
Q3 | $3.19M | Sell |
21,896
-2,492
| -10% | -$363K | ﹤0.01% | 2057 |
|
|
2020
Q2 | $3.61M | Sell |
24,388
-17,538
| -42% | -$2.6M | ﹤0.01% | 1831 |
|
|
2020
Q1 | $4.56M | Buy |
41,926
+9,146
| +28% | +$995K | ﹤0.01% | 1566 |
|
|
2019
Q4 | $3.78M | Sell |
32,780
-38,285
| -54% | -$4.41M | ﹤0.01% | 2221 |
|
|
2019
Q3 | $5.71M | Buy |
71,065
+42,701
| +151% | +$3.43M | ﹤0.01% | 1747 |
|
|
2019
Q2 | $2.06M | Sell |
28,364
-20,270
| -42% | -$1.47M | ﹤0.01% | 2489 |
|
|
2019
Q1 | $4.54M | Sell |
48,634
-55,999
| -54% | -$5.23M | ﹤0.01% | 1840 |
|
|
2018
Q4 | $7.63M | Buy |
104,633
+11,771
| +13% | +$858K | ﹤0.01% | 1417 |
|
|
2018
Q3 | $8.13M | Buy |
92,862
+38,830
| +72% | +$3.4M | ﹤0.01% | 1547 |
|
|
2018
Q2 | $5.32M | Sell |
54,032
-43,989
| -45% | -$4.33M | ﹤0.01% | 1823 |
|
|
2018
Q1 | $11.7M | Buy |
98,021
+18,107
| +23% | +$2.16M | 0.01% | 1233 |
|
|
2017
Q4 | $10.2M | Buy |
79,914
+36,548
| +84% | +$4.64M | ﹤0.01% | 1325 |
|
|
2017
Q3 | $5.1M | Sell |
43,366
-22,701
| -34% | -$2.67M | ﹤0.01% | 1725 |
|
|
2017
Q2 | $5.27M | Buy |
66,067
+4,082
| +7% | +$326K | ﹤0.01% | 1659 |
|
|
2017
Q1 | $3.18M | Sell |
61,985
-50,301
| -45% | -$2.58M | ﹤0.01% | 1967 |
|
|
2016
Q4 | $4.2M | Buy |
112,286
+48,686
| +77% | +$1.82M | ﹤0.01% | 1726 |
|
|
2016
Q3 | $4.31M | Sell |
63,600
-32,240
| -34% | -$2.18M | ﹤0.01% | 1653 |
|
|
2016
Q2 | $5.32M | Buy |
95,840
+54,805
| +134% | +$3.04M | ﹤0.01% | 1466 |
|
|
2016
Q1 | $2.58M | Sell |
41,035
-73,320
| -64% | -$4.6M | ﹤0.01% | 1949 |
|
|
2015
Q4 | $10.8M | Buy |
114,355
+57,018
| +99% | +$5.37M | 0.01% | 1045 |
|
|
2015
Q3 | $4.61M | Buy |
57,337
+24,531
| +75% | +$1.97M | ﹤0.01% | 1546 |
|
|
2015
Q2 | $3.93M | Buy |
32,806
+9,470
| +41% | +$1.14M | ﹤0.01% | 1796 |
|
|
2015
Q1 | $2.44M | Sell |
23,336
-11,298
| -33% | -$1.18M | ﹤0.01% | 2153 |
|
|
2014
Q4 | $3.36M | Buy |
+34,634
| New | +$3.36M | ﹤0.01% | 1860 |
|